Acadia Pharmaceuticals reported $0 in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Adamas Pharmaceuticals ADMS:US 4.17M 125.57M
Alexion Pharmaceuticals ALXN:US $ 2532M 30M
ALKERMES ALKS:US $ 297.07M 0.63M
Alnylam Pharmaceuticals ALNY:US $ 433.15M 241.56M
Aptinyx Inc APTX:US $ 0 0
Arena Pharmaceuticals ARNA:US $ 43.5M 1.09M
Biogen BIIB:US $ 7269.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Bristol Myers Squibb BMY:US $ 45158M 1124M
Cara Therapeutics CARA:US $ 0 0
Corcept Therapeutics CORT:US $ 0M 0M
Cytokinetics CYTK:US $ 139.14M 1.75M
Eisai 4523:JP Y 92683M 2790M
Eli Lilly And LLY:US $ 16515.1M 310.6M
Gw Pharmaceuticals GWPH:US $ 15.19M 0.11M
Intercept Pharmaceuticals ICPT:US $ 575.82M 7.7M
Intra Cellular Therapies ITCI:US $ 0M 0M
Marinus Pharmaceuticals MRNS:US $ 10.97M 10.97M
Moderna Inc MRNA:US 487M 304M
Neurocrine Biosciences NBIX:US $ 326.3M 4.3M
Prothena PRTA:US $ 0M 0M
Ptc Therapeutics PTCT:US $ 1161.83M 15.06M
Sarepta Therapeutics SRPT:US $ 1092.98M 1.88M
Seattle Genetics SGEN:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vanda Pharmaceuticals VNDA:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 524.92M 5.4M
YTE INCY:US $ 34.25M 0.22M
Zogenix ZGNX:US $ 153.63M 2.18M